Is there a generic for Fenoldopam mesylate?

Yes. The FDA Orange Book lists 4 approved generic (ANDA) applications for Fenoldopam mesylate, referencing the brand CORLOPAM. Generics rated with an "A" therapeutic-equivalence code are considered substitutable for the brand.

What is the reference-listed drug for Fenoldopam mesylate?

CORLOPAM (NDA 019922, HOSPIRA) is the reference-listed drug — the approved product a generic applicant must show its version is the same as.

What dosage forms of Fenoldopam mesylate are approved?

Fenoldopam mesylate is approved in the following dosage form: injectable.

FDA Orange Book · active-ingredient family

Fenoldopam mesylate

Fenoldopam mesylate is approved as 1 brand and 4 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:CORLOPAM · NDA 019922

Brand (NDA)

Generics (ANDA)

Listed patents

Exclusivity periods

Brand (NDA) products · injectable

Product	Applicant	Application	TE	Approved
CORLOPAMRLD	HOSPIRA	NDA 019922	—	Sep 23, 1997

Generic (ANDA) products (4)

Product	Applicant	Application	TE	Approved
FENOLDOPAM MESYLATE	TEVA PARENTERAL	ANDA 077826	—	Mar 07, 2007
FENOLDOPAM MESYLATE	SANDOZ	ANDA 077155	—	Feb 15, 2005
FENOLDOPAM MESYLATE	HIKMA	ANDA 076582	—	Oct 12, 2004
FENOLDOPAM MESYLATE	LUITPOLD	ANDA 076656	—	Dec 01, 2003

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Fenoldopam mesylate — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo